Join us.

We’re working to create a just society and preserve a healthy environment for future generations. Donate today to help.

Donate

CPR Senior Policy Analyst James Goodwin Testifies on Regulation for the House Committee on Small Business

Today, CPR Senior Policy Analyst James Goodwin will testify as an expert witness on the regulatory process for a House Committee on Small Business Hearing, "Tangled in Red Tape: New Challenges for Small Manufacturers.

Goodwin's testimony highlights the economic as well as public health and safety benefits of regulations in relation to small businesses. He notes:

Over the past four decades, U.S. regulatory agencies have achieved remarkable success in establishing safeguards that protect people and the environment against unreasonable risks. During the 1960s and 1970s, rivers caught fire, cars exploded on rear impact, workers breathing benzene contracted liver cancer, and chemical haze settled over the industrial zones of the nation's cities and towns. But today, the most visible manifestations of these threats are under control, millions of people have been protected from death and debilitating injury, and environmental degradation has been slowed and even reversed in some cases.

In short, the United States is much better off because of the regulations adopted over the past 40 years. But serious hazards remain, and indeed new ones continue to emerge as new technologies develop and the U.S. economy evolves. Americans would be even better protected if the gaps that leave them and their environment vulnerable to unnecessary risks were closed. To gauge the positive impact of regulation on Americans’ lives, consider:

  • The White House Office of Management and Budget (OMB) estimates that regulatory benefits exceed regulatory costs by about 8 to 1 for significant regulations.  
  • The Environmental Protection Agency (EPA) estimates that the regulatory benefit of the Clean Air Act exceeds its costs by a 25-to-1 ratio.

The failure to regulate some hazards related to the workplace, the environment, product safety, food safety, and more, and the failure to enforce existing regulations on such hazards results in thousands of deaths, tens of thousands of injuries, and billions of dollars in economic damages every year. Sometimes, the damages are spectacular on a world-wide scale.

The BP Oil Spill caused tens of billions of dollars in damages.3 The Wall Street collapse may have caused trillions. Regulation to prevent catastrophe can be far cheaper, and less painful, than cleaning up damage to lives, property, and the environment later.

To read his full testimony click here.

Showing 2,824 results

Erin Kesler | March 18, 2015

CPR Senior Policy Analyst James Goodwin Testifies on Regulation for the House Committee on Small Business

Today, CPR Senior Policy Analyst James Goodwin will testify as an expert witness on the regulatory process for a House Committee on Small Business Hearing, “Tangled in Red Tape: New Challenges for Small Manufacturers.”  Goodwin’s testimony highlights the economic as well as public health and safety benefits of regulations in relation to small businesses. He notes: […]

Matt Shudtz | March 16, 2015

CPR Scholars Call on Senators to Enact Meaningful Reform of the Toxic Substances Control Act

What’s old is new again. This week, competing bills to reform the 40-year old Toxic Substances Control Act (TSCA) hit the Senate—one from Senators Vitter and Udall, the other from Senators Boxer and Markey. Both the environmental community and the chemical industry agree that TSCA is broken and must be fixed. This is a law that’s so poorly […]

Celeste Monforton | March 9, 2015

Congress squeezes Obama’s reg czar about lack of transparency

This blog is cross-posted from the Pump Handle.  It’s a rare thing on Capitol Hill when a member of the Administration is on the hot seat from both sides of the aisle. But that’s what happened on Tuesday when President Obama’s regulatory czar, Howard Shelanski, JD, PhD, testified at a joint hearing of two subcommittees of the House […]

Daniel Farber | March 9, 2015

Econ101, Ideological Blinders, and the New Head of CBO

There are troubling indications that Keith Hall lets ideology blind him to basic economics. Last week, in a post about the employment effect of regulations, I mentioned briefly that the new Director of the Congressional Budget Office, Keith Hall, had endorsed some questionable views on the subject.  A reader pointed me toward an additional writing […]

James Goodwin | March 4, 2015

Three Quick Reactions to Yesterday’s House Oversight Committee Hearing on OIRA

Yesterday, the House Oversight Committee held a hearing on “Challenges Facing OIRA in Ensuring Transparency and Effective Rulemaking” that featured as its only witness the head of the White House’s Office of Information and Regulatory Affairs (OIRA), Administrator Howard Shelanski.   Given that regulations are a huge source of consternation on the Hill, and the prominent […]

Erin Kesler | March 3, 2015

CPR’s Tom McGarity in Austin-American Statesman: Public Utility Commission rule would hurt consumers

The Texas Public Utility Commission, which sets electricity rates for the state and allows adjustments for fuel costs, has recently proposed amendments to its procedural rules that would limit consumer advocate input into potentially abusive rate changes. Prior to any rate changes, the Commission holds public hearings where experts for the utility companies present highly technical reports drawn from their own data. […]

Daniel Farber | March 2, 2015

Accounting for Job Loss — The consequences of doing so may not be what you’d expect

The Republicans’ choice for head of the CBO, Keith Hall, spent some time at a libertarian think tank reportedly funded by the Koch brothers, where he wrote about the effect of regulation on employment. Hall argued that regulations cause unemployment (include indirect effects because of price changes), and that the costs of unemployment should be included in regulatory cost-benefit analysis. […]

Matthew Freeman | March 1, 2015

Bad Feds, Deadly Meds: Steinzor in USA Today

Last December, the Justice Department announced the indictiment of the owner/head pharmacist, the supervising pharmacist, and 12 others associated with the New England Compounding Compounding Center. The 131-count indictment, which included 25 charges of second-degree murder, grew out of a 2012 outbreak of fungal meningitis caused by contaminated drugs manufactured by the company. More than […]

James Goodwin | February 27, 2015

More Fun Than Escaped Llamas: House GOP to Hold Yet Another Antiregulatory Hearing

In keeping with an apparent effort to hold an antiregulatory hearing on any and all days ending in “y,” Congressional Republicans have teed up yet another humdinger for Monday, March 2. That’s when the House Judiciary Committee’s Subcommittee on Regulatory Reform, Commercial and Administrative law will take a closer look at three more antiregulatory bills […]